Patient Support Services Contact Us
Image: Coherus Investors

News

01/13/20
Agreement Includes an Option for Rituxan® Biosimilar REDWOOD CITY, Calif. , Jan. 13, 2020 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced the Company has entered into a licensing agreement with Innovent Biologics , (Suzhou) Co., Ltd.,
01/03/20
REDWOOD CITY, Calif. , Jan. 03, 2020 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will present at the 38 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2020 at 11:00 a.m. PT , being held in San Francisco .